Gold Standard/Elsevier Launches MedCounselor Consumer Drug Information Modules
August 06 2009 - 7:15AM
PR Newswire (US)
MedCounselor Helps Pharmacies and Healthcare Web Sites Attract and
Retain Consumers Seeking Quality, Real-Time Medication Information
TAMPA, Fla., Aug. 6 /PRNewswire/ -- Gold Standard/Elsevier,
publisher of medication management solutions, announced today the
launch of three MedCounselor consumer drug information modules for
pharmacies and health information Web sites. MedCounselor educates
consumers on how to take medications safely, assists in identifying
unknown tablets or capsules and checks for drug interactions. The
modules are indispensable in helping to increase consumer
compliance to their drug regimens and avoid costly and sometimes
deadly medication errors. Developed from Gold Standard/Elsevier's
award-winning drug information and medication management content
for health professionals, MedCounselor provides evidence-based,
easily understandable consumer medication information. "Pharmacies
and health Web sites are on the front lines of healthcare, serving
as accessible and familiar resources for consumers who want fast,
accurate answers to their health questions," said Karl Matuszewski,
MS, PharmD, Vice President and Editor-in-Chief at Gold
Standard/Elsevier. "The sound, timely and useful information
available through MedCounselor makes it a trusted resource that
consumers will return to often for medication guidance and
support." MedCounselor's modules include: -- Drug Information:
Updated "live"; covers need-to-know instructions for all commonly
prescribed U.S. prescription drugs, plus hard-to-find information
on herbals, vitamins and over-the-counter (OTC) products. -- Drug
Interactions: Screens for interactions between prescription, OTC,
herbal and nutritional products, as well as caffeine, food, tobacco
and alcohol; severity rankings help to prioritize the alerts. --
Drug IDentifier: Assists consumers in identifying unknown tablets
and capsules; allows for search by marking/imprint, shape and
color; results include product descriptions and full-color drug
images. MedCounselor also offers a new "Toolkit" which enables
better integration with the client's existing content; clients can
integrate searching and/or link to Drug Information directly from
their own Web sites and applications. Gold Standard/Elsevier will
demonstrate these new MedCounselor modules at the NACDS Pharmacy
& Technology Conference, August 8-11, 2009, in Boston, Booth
#1166. For more information on MedCounselor, please call
800-375-0943 or email . About Gold Standard Based in Tampa, FL,
Gold Standard/ELSEVIER uses innovative technologies to provide a
complete suite of drug information and decision support solutions.
With a tenacious commitment to product quality, Gold
Standard/ELSEVIER solutions empower healthcare organizations,
professionals and consumers to meet the most pressing healthcare
challenges, improve patient safety and ensure optimal outcomes. To
learn more about Gold Standard/ELSEVIER, visit
http://www.goldstandard.com/. About Elsevier Elsevier is a
world-leading publisher of scientific, technical and medical
information products and services. Working in partnership with the
global science and health communities, Elsevier's 7,000 employees
in over 70 offices worldwide publish more than 2,000 journals and
1,900 new books per year, in addition to offering a suite of
innovative electronic products, such as ScienceDirect
(http://www.sciencedirect.com/), MD Consult
(http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/),
bibliographic databases, and online reference works. Elsevier
(http://www.elsevier.com/) is a global business headquartered in
Amsterdam, The Netherlands and has offices worldwide. Elsevier is
part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a
world-leading publisher and information provider. Operating in the
science and medical, legal, education and business-to-business
sectors, Reed Elsevier provides high-quality and flexible
information solutions to users, with increasing emphasis on the
Internet as a means of delivery. Reed Elsevier's ticker symbols are
REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL
(New York Stock Exchange). Tom Reller Director of Corp. Relations,
Elsevier 212.462.1912 DATASOURCE: Gold Standard/Elsevier CONTACT:
Tom Reller, Director of Corp. Relations, Elsevier, +1-212-462-1912,
Web Site: http://www.goldstandard.com/ http://www.elsevier.com/
Copyright